Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Oct 14, 2012; 18(38): 5321-5323
Published online Oct 14, 2012. doi: 10.3748/wjg.v18.i38.5321
Published online Oct 14, 2012. doi: 10.3748/wjg.v18.i38.5321
c-Met in pancreatic cancer stem cells: Therapeutic implications
Marta Herreros-Villanueva, Division of Oncology Research, Department of Medicine, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, United States
Aizpea Zubia-Olascoaga, IkerChem, Oncology Therapeutics Department, 20009 San Sebastian, Spain
Luis Bujanda, Department of Gastroenterology, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Donostia Hospital-Biodonostia Institute, University of the Basque Country, 20014 San Sebastian, Spain
Author contributions: Herreros-Villanueva M, Zubia-Olascoaga A and Bujanda L designed and wrote the review.
Correspondence to: Luis Bujanda, MD, PhD, Department of Gastroenterology, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Donostia Hospital-Biodonostia Institute, University of the Basque Country, 20014 San Sebastian, Spain. luis.bujanda@osakidetza.net
Telephone: +34-94-3007173 Fax: +34-94-3007065
Received: June 29, 2012
Revised: August 1, 2012
Accepted: August 3, 2012
Published online: October 14, 2012
Revised: August 1, 2012
Accepted: August 3, 2012
Published online: October 14, 2012
Core Tip